Mivebresib (ABBV-075) CAS:1445993-26-9
Mivebresib
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-1562 | 50mg | 365.00 | + Add to cart  | 
																					|
| R-C-1562 | 100mg | 700.00 | + Add to cart  | 
																					|
| R-C-1562 | 200mg | 1150.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							Mivebresib(ABBV-075)is a novel BET family bromodomain inhibitor.It binds bromodomains of BRD2/4/Twith similar affinities(Ki of 1-2.2nM)and highly selective for 18 bromodomain proteins tested (Kd>1μM;more than 600-fold selectivity vs.BRD4),but exhibits roughly 10-fold weaker potency towards BRD3 (Ki of 12.2 nM)and has moderate activity towards CREBBP(Kd=87μM;54-fold selectivity vs.BRD4).Mivebresib(ABBV-075)efficiently triggers apoptosis in various tumor cell.
								| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 2 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds---Mivebresib 
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

